15.09.2016 • News

Evonik Idles US SAP Plants

(c) Evonik
(c) Evonik

Poor market conditions have forced Germany’s Evonik to scale back production of superabsorbent polymers (SAP) in the US. Production lines at the company’s plants in Garyville and Greensboro, North Carolina, are to be idled in response to lower demand, removing 40,000 t/y of capacity and taking total output down to 530,000 t/y. Timing for the lines’ closure was not disclosed.

“With this measure we’re adapting to demand trends. We plan to take the opportunity to bring capacity to the technological state of the art and to start up the lines again in 1-2 years,” said Norbert Westerholt, head of Evonik’s Baby Care business line. Global demand growth for SAP is expected to grow by about 6-7% per year through 2020, according to analysis by information provider IHS, but demand in the mature markets of North America and northwest Europe will stay fairly flat.

Evonik has five superabsorbents sites worldwide. As well as the two US plants, it has SAP production at Krefeld and Rheinmünster in Germany, and in a joint venture – Saudi Acrylic Polymers – in Jubail, Saudi Arabia.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read